Sparsentan-d5 (RE-021-d5)

Ask the supplier | View on supplier's website
An isotope labelled Sparsentan. Sparsentan could be the first FDA-approved pharmacologic treatment for focal segmental glomerulosclerosis (FSGS).
Supplier BOC Sciences
Product # 1801597-09-0
Pricing Inquire
Cas 1801597-09-0
Molecular Weight 597.79
Molecular Formula C32H35N4O5SD5
Feedback